Arthur Hayes Leads $6.9M Raise for BIO Protocol
The Maelstrom Fund founder is betting the next big crypto breakout will be in biotech.
Arthur Hayes, current CIO of the Maelstrom Fund, is doubling down on decentralized science, with his firm leading a nearly $7 million seed investment into Bio Protocol.
What’s the Scoop?
- $6.9M for DeSci’s New Star: Bio Protocol’s seed raise was anchored by Maelstrom, with Mechanism Capital, Animoca Brands, and Atria Ventures joining in.
- Hayes Sees a New Launchpad: Calling Bio “a category-defining launchpad,” Hayes said it aims to fund research based on community appeal rather than academic gatekeeping. If successful, it could birth a new AI-native research market.
- AI-Powered Science Agents: Bio Protocol’s platform allows users to deploy BioAgents – autonomous AI “co-scientists” that generate hypotheses, manage wallets, and commercialize discoveries.
Decoding BIO Protocol & DeSci’s Big Dreams on Bankless
How Decentralized Science teams are gearing up to tackle moonshot challenges through onchain coordination.
David Christopher Jan 8, 2025 • 6 min read
Bankless
It’s time to break up with your bank, and join the movement for a better world.
